Skip to Content

2,521 Results Found

  • Review
  • Open Access
54 Citations
9,051 Views
24 Pages

Exosomes as Natural Nanocarriers for RNA-Based Therapy and Prophylaxis

  • Andrey Gorshkov,
  • Lada Purvinsh,
  • Alexandra Brodskaia and
  • Andrey Vasin

2 February 2022

Exosomes are natural nanocontainers actively secreted by the body’s cells and transmitting molecular signals of various types to recipient cells. Cellular mechanisms of exosomes’ biogenesis involve specific sorting of RNA for incorporatio...

  • Review
  • Open Access
2 Citations
2,883 Views
13 Pages

MicroRNA Profile, Putative Diagnostic Biomarkers and RNA-Based Therapies in the Inherited Lipid Storage Disease Niemann-Pick Type C

  • Marisa Encarnação,
  • Hugo David,
  • Maria Francisca Coutinho,
  • Luciana Moreira and
  • Sandra Alves

23 September 2023

Lipids are essential for cellular function and are tightly controlled at the transcriptional and post-transcriptional levels. Dysregulation of these pathways is associated with vascular diseases, diabetes, cancer, and several inherited metabolic diso...

(This article belongs to the Section Gene and Cell Therapy)
  • Review
  • Open Access
62 Citations
18,743 Views
30 Pages

Many conditions can benefit from RNA-based therapies, namely, those targeting internal ribosome entry sites (IRESs) and their regulatory proteins, the IRES trans-acting factors (ITAFs). IRES-mediated translation is an alternative mechanism of transla...

(This article belongs to the Section Endocrinology and Metabolism Research)
  • Review
  • Open Access
11 Citations
5,723 Views
10 Pages

What Can RNA-Based Therapy Do for Monogenic Diseases?

  • Luka A. Clarke and
  • Margarida D. Amaral

The use of RNA-based approaches to treat monogenic diseases (i.e., hereditary disorders caused by mutations in single genes) has been developed on different fronts. One approach uses small antisense oligonucleotides (ASOs) to modulate RNA processing...

(This article belongs to the Special Issue mRNA-Based Protein Replacement Therapy)
  • Review
  • Open Access
7 Citations
5,406 Views
16 Pages

Engineering Nanomedicine for Non-Viral RNA-Based Gene Therapy of Glioblastoma

  • Wenya He,
  • Ningyang Wang,
  • Yaping Wang,
  • Mengyao Liu and ,
  • Qian Qing,
  • Qihang Su,
  • Yan Zou and
  • Yang Liu
  • + 3 authors+ 0 author

Glioblastoma multiforme (GBM) is the most common type of malignant tumor of the central nervous system, characterized by aggressiveness, genetic instability, heterogenesis, and unpredictable clinical behavior. Disappointing results from the current c...

(This article belongs to the Section Gene and Cell Therapy)
  • Review
  • Open Access
6 Citations
3,423 Views
17 Pages

The Role of Gene Therapy and RNA-Based Therapeutic Strategies in Diabetes

  • Mustafa Tariq Khan,
  • Reem Emad Al-Dhaleai,
  • Sarah M. Alayadhi,
  • Zainab Alhalwachi and
  • Alexandra E. Butler

22 October 2025

Gene therapy and RNA (ribonucleic acid)-based therapeutic strategies have emerged as promising alternatives to conventional diabetes treatments, significantly expanding the therapeutic landscape using viral and non-viral vectors, and RNA modalities s...

(This article belongs to the Special Issue Innovative Strategies to Target Metabolism, Inflammation, and Oxidative Stress in Human Diseases)
  • Review
  • Open Access
46 Citations
7,014 Views
30 Pages

Triple-negative breast cancer (TNBC) is a highly heterogeneous and aggressive cancer that has the highest mortality rate out of all breast cancer subtypes. Conventional clinical treatments targeting ER, PR, and HER2 receptors have been unsuccessful i...

(This article belongs to the Special Issue mRNA Therapeutics: A Themed Issue in Honor of Professor Katalin Karikó)
  • Review
  • Open Access
18 Citations
5,581 Views
26 Pages

28 September 2023

In the last few decades, RNA-based drugs have emerged as a promising candidate in the treatment of various diseases. The introduction of messenger RNA (mRNA) as a vaccine or therapeutic agent enables the production of almost any functional protein/pe...

(This article belongs to the Special Issue Advances in Targeted Immunotherapy in Cancers)
  • Review
  • Open Access
97 Citations
19,239 Views
24 Pages

An Update on Gene Therapy for Inherited Retinal Dystrophy: Experience in Leber Congenital Amaurosis Clinical Trials

  • Wei Chiu,
  • Ting-Yi Lin,
  • Yun-Chia Chang,
  • Henkie Isahwan-Ahmad Mulyadi Lai and ,
  • Shen-Che Lin,
  • Chun Ma,
  • Aliaksandr A. Yarmishyn,
  • Shiuan-Chen Lin,
  • Kao-Jung Chang and
  • De-Kuang Hwang
  • + 11 authors+ 6 authors

Inherited retinal dystrophies (IRDs) are a group of rare eye diseases caused by gene mutations that result in the degradation of cone and rod photoreceptors or the retinal pigment epithelium. Retinal degradation progress is often irreversible, with c...

(This article belongs to the Special Issue Towards an Understanding of Retinal Diseases and Novel Treatment)
  • Review
  • Open Access
4 Citations
2,411 Views
21 Pages

Novel Biological Strategies for Melanoma Therapy: A Focus on lncRNAs and Their Targeting

  • Francesca Maria Orlandella,
  • Rosaria Arcone,
  • Neila Luciano,
  • Giuliana Salvatore and
  • Maria Letizia Motti

9 April 2025

Increasing evidence revealed that restoring the correct expression of lncRNAs could have implications in the management of melanoma patients. In this context, here, we aim to dissect the main characteristics of lncRNAs altered in melanoma and their c...

(This article belongs to the Section Cancer Drug Development)
  • Review
  • Open Access
24 Citations
6,533 Views
40 Pages

26 December 2024

Spinal cord injury (SCI) initiates a cascade of secondary damage driven by oxidative stress, characterized by the excessive production of reactive oxygen species and other reactive molecules, which exacerbate cellular and tissue damage through the ac...

  • Review
  • Open Access
1 Citations
2,328 Views
23 Pages

Nuclear Receptors in Bladder Cancer: Insights into miRNA-Mediated Regulation and Potential Therapeutic Implications

  • José Javier Flores-Estrada,
  • Adriana Jiménez,
  • Georgina Victoria-Acosta,
  • Enoc Mariano Cortés-Malagón and ,
  • María Guadalupe Ortiz-López,
  • María Elizbeth Alvarez-Sánchez,
  • Stephanie I. Nuñez-Olvera,
  • Yussel Fernando Pérez-Navarro,
  • Marcos Morales-Reyna and
  • Jonathan Puente-Rivera
  • + 5 authors+ 0 author

Nuclear receptors (NRs) are ligand-activated transcription factors that regulate gene expression and are involved in diverse physiological and pathological processes, including carcinogenesis. In bladder cancer (BCa), dysregulation of NR signaling pa...

(This article belongs to the Special Issue Urologic Cancers: Molecular Basis for Novel Therapeutic Approaches)
  • Review
  • Open Access
5 Citations
5,615 Views
23 Pages

Contemporary and Emerging Therapeutics in Cardiovascular-Kidney-Metabolic (CKM) Syndrome: In Memory of Professor Akira Endo

  • Inderjeet Singh Bharaj,
  • Ajit Brar,
  • Aayushi Kacheria,
  • Karen Purewal and ,
  • Austin Simister,
  • Umabalan Thirupathy,
  • Palak Gupta,
  • Jasraj Kahlon,
  • Juzer Munaim and
  • Krishnaswami Vijayaraghavan
  • + 8 authors+ 3 authors

Cardiovascular-kidney-metabolic (CKM) syndrome is a multifaceted, systemic disorder characterized by the interplay of cardiovascular disease (CVD), chronic kidney disease (CKD), type 2 diabetes mellitus (T2DM), and obesity. This review synthesizes cu...

(This article belongs to the Special Issue New Advances in Cardiovascular Drugs: In Memory of Professor Akira Endo)
  • Review
  • Open Access
4 Citations
7,991 Views
19 Pages

30 June 2025

Duchenne muscular dystrophy (DMD) is a severe inherited muscle-wasting disorder that is associated with severe morbidity and mortality globally. Current treatment options have improved the quality of life of patients, but these treatments are only pa...

(This article belongs to the Section Human Genomics and Genetic Diseases)
  • Review
  • Open Access
16 Citations
5,801 Views
13 Pages

Lipid-Based Nanocarriers in Renal RNA Therapy

  • Chi-Ting Su,
  • Daniel H. W. See and
  • Jenq-Wen Huang

Kidney disease is a multifactorial problem, with a growing prevalence and an increasing global burden. With the latest worldwide data suggesting that chronic kidney disease (CKD) is the 12th leading cause of death, it is no surprise that CKD remains...

(This article belongs to the Special Issue Lipid-Based Nanocarriers)
  • Review
  • Open Access
34 Citations
6,972 Views
26 Pages

Inflammaging and Senescence-Driven Extracellular Matrix Remodeling in Age-Associated Cardiovascular Disease

  • Ewelina Młynarska,
  • Adrianna Kowalik,
  • Agnieszka Krajewska,
  • Natalia Krupińska and ,
  • Weronika Marcinkowska,
  • Jakub Motor,
  • Aleksandra Przybylak,
  • Katarzyna Tłustochowicz,
  • Jacek Rysz and
  • Beata Franczyk
  • + 5 authors+ 0 author

14 October 2025

Cardiovascular aging is a multifactorial and systemic process that contributes significantly to the global burden of cardiovascular disease, particularly in older populations. This review explores the molecular and cellular mechanisms underlying card...

(This article belongs to the Section Molecular Biology)
  • Review
  • Open Access
16 Citations
5,367 Views
22 Pages

Novel RNA-Based Therapies in the Management of Dyslipidemias

  • Constantine E. Kosmas,
  • Maria D. Bousvarou,
  • Donatos Tsamoulis,
  • Maria Gianniou and ,
  • Evangelia J. Papakonstantinou and
  • Loukianos S. Rallidis
  • + 1 author+ 0 author

25 January 2025

Pharmaceutical advancements and an improved understanding of pathophysiology have enabled innovative therapies for chronic conditions like dyslipidemia. This condition is marked by abnormalities in lipid homeostasis. Nucleic acid therapeutics, includ...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Review
  • Open Access
10 Citations
4,580 Views
29 Pages

Targeting the Eye: RNA-Based Therapies, Interferences, and Delivery Strategies

  • Mohammed S. Abdel-Raziq Hassan,
  • Cheng Zhong,
  • Fatma Hassan and
  • S. Kevin Li

Recent advances in molecular biology have led to the development of RNA-based therapeutics, offering significant promise for treating various eye diseases. Current RNA therapeutics include RNA aptamers, antisense oligonucleotides (ASOs), small interf...

(This article belongs to the Section Nanomedicine and Nanotechnology)
  • Perspective
  • Open Access
3 Citations
3,903 Views
136 Pages

The present Perspective analyzes the remarkable evolution of the Amyloid Cascade Hypothesis 2.0 (ACH2.0) theory of Alzheimer’s disease (AD) since its inception a few years ago, as reflected in the diminishing role of amyloid-beta (Aβ) in t...

(This article belongs to the Special Issue Traumatic Brain Injury/Chronic Traumatic Encephalopathy as Cause of Alzheimer’s Disease: Physics and Molecular Biology in the Genesis of Neurodegeneration?)
  • Review
  • Open Access
1,323 Views
20 Pages

Rett syndrome (RTT) is a severe X-linked neurodevelopmental disorder that is caused in most cases by pathogenic variants in MECP2, the gene encoding methyl-CpG-binding protein 2 (MeCP2). Despite substantial progress in the development of gene therapy...

(This article belongs to the Section Clinical Applications of Non-Coding RNA)
  • Review
  • Open Access
75 Citations
8,898 Views
23 Pages

MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges?

  • Han Yang,
  • Yufang Liu,
  • Longqing Chen,
  • Juanjuan Zhao and ,
  • Mengmeng Guo,
  • Xu Zhao,
  • Zhenke Wen,
  • Zhixu He,
  • Chao Chen and
  • Lin Xu
  • + 5 authors+ 0 author

Lung cancer is a commonly diagnosed cancer and the leading cause of cancer-related deaths, posing a serious health risk. Despite new advances in immune checkpoint and targeted therapies in recent years, the prognosis for lung cancer patients, especia...

  • Review
  • Open Access
634 Citations
23,955 Views
18 Pages

MicroRNA-Based Diagnosis and Therapy

  • Phuong T. B. Ho,
  • Ian M. Clark and
  • Linh T. T. Le

MicroRNAs (miRNAs) are a group of endogenous non-coding RNAs that regulate gene expression. Alteration in miRNA expression results in changes in the profile of genes involving a range of biological processes, contributing to numerous human disorders....

(This article belongs to the Special Issue Transcriptomics in Health and Disease)
  • Review
  • Open Access
4 Citations
2,434 Views
22 Pages

14 February 2026

RNA editing is a way to diversify, regulate expression, and expand the cell transcriptome. The most common RNA editing is the reversible conversion of adenosine (A) to inosine (I) driven by double-stranded RNA-binding adenosine deaminases (ADARs). As...

(This article belongs to the Special Issue Epigenetic and Post-Transcriptional Regulation of Gene Expression)
  • Perspective
  • Open Access
1,303 Views
100 Pages

2 February 2026

In the Amyloid Cascade Hypothesis (ACH2.0) paradigm, Alzheimer’s disease (AD) is defined as a disorder triggered by a sustained neuronal integrated stress response (ISR) and driven by the C99 fragment of amyloid-beta protein precursor (AβP...

(This article belongs to the Special Issue 25th Anniversary of IJMS: Updates and Advances in Molecular Neurobiology)
  • Review
  • Open Access
50 Citations
9,372 Views
23 Pages

The Ins and Outs of Messenger RNA Electroporation for Physical Gene Delivery in Immune Cell-Based Therapy

  • Diana Campillo-Davo,
  • Maxime De Laere,
  • Gils Roex,
  • Maarten Versteven and ,
  • Donovan Flumens,
  • Zwi N. Berneman,
  • Viggo F. I. Van Tendeloo,
  • Sébastien Anguille and
  • Eva Lion
  • + 4 authors+ 0 author

Messenger RNA (mRNA) electroporation is a powerful tool for transient genetic modification of cells. This non-viral method of genetic engineering has been widely used in immunotherapy. Electroporation allows fine-tuning of transfection protocols for...

(This article belongs to the Special Issue Delivery Systems of Plasmid DNA and Messenger RNA for Advanced Therapies)
  • Review
  • Open Access
7 Citations
3,626 Views
20 Pages

Advanced Immunomodulation in Rheumatoid Arthritis: Immune Checkpoints, microRNAs, and Cell-Based Therapies

  • Sandra Pascual-García,
  • Raúl Cobo,
  • José Luis Bolinches,
  • Iván Ortiz and ,
  • Pedro Viamonte,
  • José Miguel Sempere-Ortells and
  • Pascual Martínez-Peinado
  • + 2 authors+ 0 author

Background/Objectives: Rheumatoid arthritis (RA) is a chronic autoimmune disorder marked by persistent synovial inflammation, progressive joint destruction, and systemic complications. Despite significant progress in targeted therapies, major clinica...

(This article belongs to the Special Issue Pathogenesis, Diagnostics, and Therapeutics for Rheumatic Diseases)
  • Review
  • Open Access
33 Citations
5,642 Views
17 Pages

Recent Advances in miRNA-Based Therapy for MASLD/MASH and MASH-Associated HCC

  • Sara Carpi,
  • Simona Daniele,
  • Jacqueline Fátima Martins de Almeida and
  • Daniela Gabbia

14 November 2024

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is a growing health concern worldwide, affecting more than 1 billion adults. It may progress to metabolic dysfunction-assoc...

(This article belongs to the Special Issue Chronic Liver Disease and Hepatocellular Carcinoma)
  • Perspective
  • Open Access
4 Citations
5,454 Views
15 Pages

8 January 2024

The use of mRNA-based immunotherapies that leverage the genomes of oncolytic viruses holds significant promise in addressing glioblastoma (GBM), an exceptionally aggressive neurological tumor. We explore the significance of mRNA-based platforms in th...

(This article belongs to the Section Vaccination Against Cancer and Chronic Diseases)
  • Review
  • Open Access
12 Citations
13,640 Views
23 Pages

12 December 2013

In the absence of an effective vaccine and lack of a complete cure, gene therapy approaches to control HIV infection offer feasible alternatives. Due to the chronic nature of infection, a wide window of opportunity exists to gene modify the HIV susce...

(This article belongs to the Special Issue Gene Therapy for Retroviral Infections)
  • Review
  • Open Access
171 Views
22 Pages

Corneal Endothelial Injury Repair: Cellular Mechanisms, Molecular Regulation, and Therapeutic Strategies

  • Liyuan Wang,
  • Ziqian Geng,
  • Lin Zhu,
  • Longfei Li and ,
  • Wanyi Xie,
  • Song Yang and
  • Bin Xu
  • + 2 authors+ 0 author

30 October 2026

Background/Objectives: Corneal endothelial cells (CECs) maintain corneal transparency through barrier and pump functions but have minimal proliferative activity in the adult human eye. After injury, repair relies mainly on migration, spreading, and e...

(This article belongs to the Special Issue Ophthalmic Drugs and Pharmacology)
  • Review
  • Open Access
15 Citations
11,104 Views
18 Pages

Nucleic acids, as carriers of genetic information, have found wide applications in both medical and research fields, including gene editing, disease diagnostics, and drug development. Among various types of nucleic acids, RNA offers greater versatili...

(This article belongs to the Section Biochemistry, Molecular and Cellular Biology)
  • Review
  • Open Access
11 Citations
3,972 Views
19 Pages

Oxidative Stress Modulation by ncRNAs and Their Emerging Role as Therapeutic Targets in Atherosclerosis and Non-Alcoholic Fatty Liver Disease

  • Jorge Infante-Menéndez,
  • Paula González-López,
  • Raquel Huertas-Lárez,
  • Almudena Gómez-Hernández and
  • Óscar Escribano

24 January 2023

Atherosclerosis and non-alcoholic fatty liver disease (NAFLD) are pathologies related to ectopic fat accumulation, both of which are continuously increasing in prevalence. These threats are prompting researchers to develop effective therapies for the...

(This article belongs to the Special Issue 10th Anniversary of Antioxidants—Review Collection)
  • Review
  • Open Access
18 Citations
7,331 Views
24 Pages

Development of Engineered-U1 snRNA Therapies: Current Status

  • Mariana Gonçalves,
  • Juliana Inês Santos,
  • Maria Francisca Coutinho,
  • Liliana Matos and
  • Sandra Alves

27 September 2023

Splicing of pre-mRNA is a crucial regulatory stage in the pathway of gene expression. The majority of human genes that encode proteins undergo alternative pre-mRNA splicing and mutations that affect splicing are more prevalent than previously thought...

(This article belongs to the Special Issue Future Challenges and Trends of Nucleic Acids)
  • Review
  • Open Access
22 Citations
4,413 Views
28 Pages

Therapeutic Applications of Poly-miRNAs and miRNA Sponges

  • Cynthia Avendaño-Portugal,
  • Mariela Montaño-Samaniego,
  • Raquel Guttman-Bazbaz,
  • Diana M. Bravo-Estupiñan and
  • Miguel Ibáñez-Hernández

MicroRNAs (miRNAs) are small, non-coding RNA molecules that play crucial roles in regulating gene expression, and their dysregulation is implicated in various human diseases. Over the years, several research groups have identified miRNAs as promising...

(This article belongs to the Special Issue Role of MicroRNAs in Human Diseases: 2nd Edition)
  • Review
  • Open Access
3 Citations
6,499 Views
26 Pages

Splicing Modulation as a Promising Therapeutic Strategy for Lysosomal Storage Disorders: The Mucopolysaccharidoses Example

  • Juliana Inês Santos,
  • Mariana Gonçalves,
  • Liliana Matos,
  • Luciana Moreira and ,
  • Sofia Carvalho,
  • Maria João Prata,
  • Maria Francisca Coutinho and
  • Sandra Alves
  • + 3 authors+ 0 author

19 April 2022

Over recent decades, the many functions of RNA have become more evident. This molecule has been recognized not only as a carrier of genetic information, but also as a specific and essential regulator of gene expression. Different RNA species have bee...

(This article belongs to the Special Issue New Insights into Lysosomal Storage Disorders and Other Rare Genetic Diseases)
  • Review
  • Open Access
23 Citations
4,872 Views
14 Pages

miRNA Pathway Alteration in Response to Non-Coding RNA Delivery in Viral Vector-Based Gene Therapy

  • Darya A. Savenkova,
  • Aelita-Luiza A. Makarova,
  • Igor K. Shalik and
  • Dmitry V. Yudkin

29 November 2022

Gene therapy is widely used to treat incurable disorders and has become a routine procedure in clinical practice. Since viruses can exhibit specific tropisms, effectively penetrate the cell, and are easy to use, most gene therapy approaches are based...

(This article belongs to the Special Issue The Role of microRNA in Human Diseases)
  • Review
  • Open Access
15 Citations
8,288 Views
37 Pages

Molecular strategies tailored to promote/correct the expression and/or processing of defective coagulation factors would represent innovative therapeutic approaches beyond standard substitutive therapy. Here, we focus on the molecular mechanisms and...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Review
  • Open Access
16 Citations
3,654 Views
21 Pages

The Role of lncRNAs in the Pathobiology and Clinical Behavior of Multiple Myeloma

  • Arantxa Carrasco-León,
  • Ane Amundarain,
  • Nahia Gómez-Echarte,
  • Felipe Prósper and
  • Xabier Agirre

20 April 2021

MM is a hematological neoplasm that is still considered an incurable disease. Besides established genetic alterations, recent studies have shown that MM pathogenesis is also characterized by epigenetic aberrations, such as the gain of de novo active...

(This article belongs to the Special Issue Molecular Features in Multiple Myeloma)
  • Review
  • Open Access
13 Citations
4,391 Views
24 Pages

Obesity and Heart Failure: Mechanistic Insights and the Regulatory Role of MicroRNAs

  • Parul Sahu,
  • Furkan Bestepe,
  • Sezan Vehbi,
  • George F. Ghanem and ,
  • Robert M. Blanton and
  • Basak Icli
  • + 1 author+ 0 author

28 May 2025

Heart failure (HF) remains a leading cause of morbidity and mortality worldwide, driven by diverse pathophysiological mechanisms. Among its major risk factors, obesity has emerged as a lobal public health concern affecting individuals across all age...

(This article belongs to the Section RNA)
  • Systematic Review
  • Open Access
6 Citations
2,221 Views
20 Pages

The Role of microRNA-210 in the Pathogenesis and Diagnosis of Preeclampsia—A Systematic Review

  • Oana Eliza Cretu,
  • Alina Alexandra Dirlau,
  • Adrian Valeriu Neacsu,
  • Adina Elena Nenciu and
  • Iuliana Ceausu

26 October 2025

Background: Preeclampsia is a complex hypertensive disorder of pregnancy associated with significant maternal and foetal morbidity and mortality. Its pathogenesis involves placental hypoxia, oxidative stress, and impaired trophoblast invasion. Recent...

(This article belongs to the Special Issue Advances in Maternal Fetal Medicine)
  • Review
  • Open Access
14 Citations
4,878 Views
22 Pages

4 September 2025

Pseudouridylation, the most abundant RNA modification, plays a critical role in modulating RNA structure, stability, and function. Among the family of pseudouridine synthases, Pseudouridine Synthase 7 (PUS7) has recently gained attention for its emer...

(This article belongs to the Special Issue Cellular and Molecular Mechanisms in Gynecological Disorders—Second Edition)
  • Article
  • Open Access
23 Citations
4,991 Views
17 Pages

NTRK Gene Fusions in Non-Small-Cell Lung Cancer: Real-World Screening Data of 1068 Unselected Patients

  • Tobias Raphael Overbeck,
  • Annika Reiffert,
  • Katja Schmitz,
  • Achim Rittmeyer and ,
  • Wolfgang Körber,
  • Sara Hugo,
  • Juliane Schnalke,
  • Laura Lukat,
  • Tabea Hugo and
  • Hans-Ulrich Schildhaus
  • + 7 authors+ 2 authors

29 May 2023

(1) Background: The main objectives of our study are (i) to determine the prevalence of NTRK (neurotrophic tyrosine kinase) fusions in a routine diagnostic setting in NSCLC (non-small cell lung cancer) and (ii) to investigate the feasibility of scree...

(This article belongs to the Section Cancer Biomarkers)
  • Review
  • Open Access
4 Citations
5,226 Views
19 Pages

RNA Targeting in Inherited Neuromuscular Disorders: Novel Therapeutic Strategies to Counteract Mis-Splicing

  • Veronica Verdile,
  • Gloria Guizzo,
  • Gabriele Ferrante and
  • Maria Paola Paronetto

22 October 2021

Neuromuscular disorders represent multifaceted abnormal conditions, with little or no cure, leading to patient deaths from complete muscle wasting and atrophy. Despite strong efforts in the past decades, development of effective treatments is still u...

(This article belongs to the Special Issue The Role of Skeletal Muscle in Neuromuscular Diseases: From Cellular and Molecular Players to Therapeutic Interventions)
  • Article
  • Open Access
2,687 Views
15 Pages

An In Vitro RNA Editing-Based Reporter Assay for Transcriptional Activity of Therapeutic Gene in Gene Therapy Products

  • Lei Yu,
  • Yong Zhou,
  • Guangyu Wang,
  • Jianning Fu and ,
  • Zhihao Fu,
  • Chenggang Liang and
  • Junzhi Wang
  • + 2 authors+ 0 author

11 November 2024

The expression of therapeutic genes is critical for the efficacy of gene therapy products. However, existing methods such as immunological analysis at the protein level or reverse-transcription PCR at the RNA level are unable to accurately quantify t...

(This article belongs to the Special Issue Advanced Analytical Tools for Characterization and Quality Control of Food, Drugs, and Natural Active Ingredients, 2nd Edition)
  • Review
  • Open Access
25 Citations
7,572 Views
24 Pages

The general background of autoimmune diseases is a combination of genetic, epigenetic and environmental factors, that lead to defective immune reactions. This erroneous immune cell activation results in an excessive production of autoantibodies and p...

(This article belongs to the Special Issue Epigenetic Drugs)
  • Review
  • Open Access
67 Citations
8,873 Views
24 Pages

Clinical Applications of Short Non-Coding RNA-Based Therapies in the Era of Precision Medicine

  • Ellen S. Smith,
  • Eric Whitty,
  • Byunghee Yoo,
  • Anna Moore and ,
  • Lorenzo F. Sempere and
  • Zdravka Medarova
  • + 1 author+ 0 author

21 March 2022

Traditional targeted therapeutic agents have relied on small synthetic molecules or large proteins, such as monoclonal antibodies. These agents leave a lot of therapeutic targets undruggable because of the lack or inaccessibility of active sites and/...

(This article belongs to the Collection Molecular Function and Clinical Value of Non-coding RNAs (ncRNAs) in Cancer Regulation)
  • Article
  • Open Access
658 Views
15 Pages

Investigation of Intracellular Clearing of Streptococcus pneumoniae by mRNA-Encoded Cpl-1 Bacteriophage Endolysin in Human Macrophages

  • Carolin Warnke,
  • Wendy Bergmann-Ewert,
  • Marc Benjamin Janssen,
  • Hendrik Feit Mueck and ,
  • Nicolas Raether,
  • Nooshin Mohebali,
  • Bernd Kreikemeyer,
  • Katharina Ekat and
  • Moritz K. Jansson
  • + 4 authors+ 0 author

Streptococcus pneumoniae remains a major global health threat and is listed by the World Health Organization as a pathogen in urgent need of new antimicrobial strategies. While primarily considered an extracellular pathogen, S. pneumoniae can persist...

(This article belongs to the Special Issue Phages: From Biology to Application in Medicine and Biotechnology)
  • Article
  • Open Access
10 Citations
5,245 Views
26 Pages

RNA-Based Strategies for Cancer Therapy: In Silico Design and Evaluation of ASOs for Targeted Exon Skipping

  • Chiara Pacelli,
  • Alice Rossi,
  • Michele Milella,
  • Teresa Colombo and
  • Loredana Le Pera

3 October 2023

Precision medicine in oncology has made significant progress in recent years by approving drugs that target specific genetic mutations. However, many cancer driver genes remain challenging to pharmacologically target (“undruggable”). To t...

(This article belongs to the Collection Feature Papers in Molecular Genetics and Genomics)
  • Review
  • Open Access
18 Citations
5,036 Views
23 Pages

Tiny miRNAs Play a Big Role in the Treatment of Breast Cancer Metastasis

  • Andrea York Tiang Teo,
  • Xiaoqiang Xiang,
  • Minh TN Le,
  • Andrea Li-Ann Wong and ,
  • Qi Zeng,
  • Lingzhi Wang and
  • Boon-Cher Goh
  • + 2 authors+ 0 author

18 January 2021

Distant organ metastases accounts for the majority of breast cancer deaths. Given the prevalence of breast cancer in women, it is imperative to understand the underlying mechanisms of its metastatic progression and identify potential targets for ther...

(This article belongs to the Special Issue Targeting Cancer Metastasis)
  • Review
  • Open Access
47 Citations
10,309 Views
27 Pages

The development of novel target therapies based on the use of RNA interference (RNAi) and antisense oligonucleotides (ASOs) is growing in an exponential way, challenging the chance for the treatment of the genetic diseases and cancer by hitting selec...

(This article belongs to the Special Issue Transcriptional Therapy and Nucleic Acid-Based Therapeutics: From Molecular Targets to Preclinical Studies)

of 51